Meta-analysis (% (95% CI)) | Raw numbers | |
---|---|---|
Complete/near complete occlusion at 3 months | 93.0 (81.0 to 98.0) | 40/41 |
Improvement in mass effect | 87.0 (57.0 to 97.0) | 30/33 |
Retreatment rate | 8.0 (3.0 to 22.0) | 1/41 |
Total periprocedural morbidity | 11.0 (4.0 to 26.0) | 3/41 |
Periprocedural stroke | 11.0 (4.0 to 26.0) | 2/41 |
Periprocedural hemorrhage | 9.0 (3.0 to 24.0) | 1/41 |
Periprocedural mortality | 7.0 (2.0 to 19.0) | 1/41 |